← 產業報告目錄
Oncology Drug Discovery & Development Market Size, Share & Trends Analysis Report By Drug/Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy, Others), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Leukemia Cancer, Lymphoma Cancer, Ovarian Cancer, Others), By Stage, By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-11頁數 180報告編號 INSIGHTACE-a383cbd8db
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Oncology Drug Discovery & Development Market is positioned for steady expansion, with a projected CAGR of 18.2% from 2025 to 2034.
Oncology Drug Discovery & Development covers key industry insights & findings from the report:
The increase in global cancer prevalence represents a major driver for the oncology drug discovery and development market. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
The market's upward path is bolstered by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region projected to deliver the strongest growth trajectory through the forecast period, bolstered by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oncology Drug Discovery & Development Market Snapshot
Chapter 4. Global Oncology Drug Discovery & Development Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Drug/Therapy Type Estimates & Trend Analysis
5.1. By Drug/Therapy Type, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Drug/Therapy Type:
5.2.1. Chemotherapy
5.2.2. Targeted Therapy
5.2.3. Immunotherapy
5.2.4. Hormone Therapy
5.2.5. Others
Chapter 6. Market Segmentation 2: By Cancer Type Estimates & Trend Analysis
6.1. By Cancer Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Cancer Type:
6.2.1. Lung Cancer
6.2.2. Breast Cancer
6.2.3. Colorectal Cancer
6.2.4. Prostate Cancer
6.2.5. Leukemia Cancer
6.2.6. Lymphoma Cancer
6.2.7. Ovarian Cancer
6.2.8. Others
Chapter 7. Market Segmentation 3: By Stage Estimates & Trend Analysis
7.1. By Stage & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Stage:
7.2.1. Discovery Phase
7.2.2. Preclinical Phase
7.2.3. Clinical Trials
7.2.4. Others
Chapter 8. Oncology Drug Discovery & Development Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Oncology Drug Discovery & Development Market revenue (US$ Million) estimates and forecasts By Drug/Therapy Type, 2021-2034
8.1.2. North America Oncology Drug Discovery & Development Market revenue (US$ Million) estimates and forecasts By Cancer Type, 2021-2034
8.1.3. North America Oncology Drug Discovery & Development Market revenue (US$ Million) estimates and forecasts By Stage, 2021-2034
8.1.4. North America Oncology Drug Discovery & Development Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Oncology Drug Discovery & Development Market revenue (US$ Million) By Drug/Therapy Type, 2021-2034
8.2.2. Europe Oncology Drug Discovery & Development Market revenue (US$ Million) By Cancer Type, 2021-2034
8.2.3. Europe Oncology Drug Discovery & Development Market revenue (US$ Million) By Stage, 2021-2034
8.2.4. Europe Oncology Drug Discovery & Development Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Oncology Drug Discovery & Development Market revenue (US$ Million) By Drug/Therapy Type, 2021-2034
8.3.2. Asia Pacific Oncology Drug Discovery & Development Market revenue (US$ Million) By Cancer Type, 2021-2034
8.3.3. Asia Pacific Oncology Drug Discovery & Development Market revenue (US$ Million) By Stage, 2021-2034
8.3.4. Asia Pacific Oncology Drug Discovery & Development Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Oncology Drug Discovery & Development Market revenue (US$ Million) By Drug/Therapy Type, (US$ Million) 2021-2034
8.4.2. Latin America Oncology Drug Discovery & Development Market revenue (US$ Million) By Cancer Type, (US$ Million) 2021-2034
8.4.3. Latin America Oncology Drug Discovery & Development Market revenue (US$ Million) By Stage, (US$ Million) 2021-2034
8.4.4. Latin America Oncology Drug Discovery & Development Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Oncology Drug Discovery & Development Market revenue (US$ Million) By Drug/Therapy Type, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Oncology Drug Discovery & Development Market revenue (US$ Million) By Cancer Type, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Oncology Drug Discovery & Development Market revenue (US$ Million) By Stage, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Oncology Drug Discovery & Development Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. F. Hoffmann-La Roche Ltd,
9.2.2. Novartis,
9.2.3. AstraZeneca,
9.2.4. Merck & Co., Inc,
9.2.5. Bristol-Myers Squibb,
9.2.6. Pfizer,
9.2.7. Eli Lilly and Company,
9.2.8. Gilead Sciences,
9.2.9. Regeneron Pharmaceuticals,
9.2.10. Takeda Pharmaceutical Company,
9.2.11. others
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們